Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Price History
|
Ratios
|
Insiders
Bullboard - Stock Discussion Forum
GRI Bio Inc
GRI
Healthcare
Biotechnology
GRI Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies that target diseases leading to inflammatory, fibrotic, and autoimmune disorders in the United States. Its lead product candidate is GRI-0621, an oral inhibitor of type 1 Natural Killer T cells, which is in phase IIa clinical trial for the treatment of severe fibrotic...
lung diseases, such as idiopathic pulmonary fibrosis. The company’s portfolio also includes GRI-0803, a novel oral agonist of type 2 Natural Killer T cells that is in preclinical development for the treatment of autoimmune disorders; a proprietary library of 500+ compounds; and GRI-0124 and GRI-0729 for balance inflammatory immune responses. GRI Bio, Inc. was formerly known as Glycoregimmune, Inc. GRI Bio, Inc. was founded in 2009 and is based in LA Jolla, California.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (NDAQ:GRI)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
Next
(1069)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 11, 2025 1:55pm
GRI....$2.06 now
Dodo bird in the making ; )
(1069)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 11, 2025 12:22pm
GRI....Great Morning
Bot the L.O.D and just sold the Rip over $2.20 Scalped Maddapakka !
(1069)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 11, 2025 10:19am
GRI....Good Morning !
sold all
(0)
•••
PressRelease
X
Post by
PressRelease
on Sep 11, 2025 8:45am
New Press Release - GRI Bio Reports 6-Week Interim Lung Function Data in Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis ("IPF")
No decline in lung function observed at 6-week interim analysis builds upon positive safety and biomarker dataPhase 2a study fully enrolled; Topline data on track for Q3 2025Currently available treatments for IPF are limited to only two approved drugs that come with significant side-effects...
read article.
(1069)
•••
Iseneschal
X
Comment by
Iseneschal
on Sep 05, 2025 3:37pm
RE:RE:GRI....might want to watch this ; )
Just tapped $1.6797 which is N.H.O.D....vols have been increasing all morning....but still not a "blow off" IMHO Expect the unexpected Buy Hold & Prosper Happy Fryday
(1069)
•••
Iseneschal
X
Comment by
Iseneschal
on Sep 05, 2025 12:09pm
RE:GRI....might want to watch this ; )
Slowly Slowly creeps the monkey.... $1.65 H.O.D this a.m....still watching with a small position. Cheers !
(1069)
•••
Iseneschal
X
Post by
Iseneschal
on Aug 14, 2025 2:39pm
GRI....trending slightly higher on low vol
$1.39 bid...offered at $1.41 Looking for a vol spike and break of $1.50
(1069)
•••
Iseneschal
X
Post by
Iseneschal
on Aug 14, 2025 1:10pm
GRI....big offers put $'s in my Coffers ; )
LFG !
(1069)
•••
Iseneschal
X
Post by
Iseneschal
on Aug 14, 2025 10:34am
GRI.....chipping away at the ask....
Now trading at $1.37 Vols are very low
(1069)
•••
Iseneschal
X
Post by
Iseneschal
on Jul 31, 2025 1:11pm
GRI....well if I liked it at $1.42...sub $1.30 is a good ...
place to start a position..... $1.28 ; ) Will add on weakness.... Cheers !
(1069)
•••
Iseneschal
X
Post by
Iseneschal
on Jul 31, 2025 12:39pm
GRI....might want to watch this ; )
There's a meeting coming up.....3 proposals... one being Directors compensation I think this is being set up for some cheap stock options Where is the bottom....LoL
(1069)
•••
Iseneschal
X
Post by
Iseneschal
on Jul 31, 2025 11:47am
GRI....Lots of whinners on Social Media re: Good NR &
the Share Price gets whacked....LoL....Lokks like a buy here at this level... $1.43 ; ) Here is the NR....You be the judge ; ) GRI Bio Reports 6-Week Interim Biomarker Data
...more
(0)
•••
PressRelease
X
Post by
PressRelease
on Apr 16, 2025 8:35am
New Press Release - GRI Bio Announces Abstract Selected for Poster Discussion Session at the 2025 American Thoracic Society (ATS) International Conference
LA JOLLA, CA, April 16, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases, today announced that...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Apr 02, 2025 4:05pm
New Press Release - GRI Bio Announces Closing of $5.0 Million Public Offering
LA JOLLA, CA, April 02, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases, today announced the...
read article.
(1069)
•••
Iseneschal
X
Comment by
Iseneschal
on Apr 02, 2025 12:18pm
RE:GRI....N.L.O.D $2.01
And you thought I was full of **it ; )
Prev
1
2
3
4
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Sorrento Resources Identifies Several High-Grade Soil Gold Anomalies up to 525m by 450m in Size, Newfoundland
Tungsten has quietly become one of the most strategic metals on the planet
TomaGold Initiates Major Phase 2 Program at Berrigan Mine to Test Berrigan Deep Potential
Alvopetro 2025 Year End Reserves Includes a 79% Increase in Reserves & Replacement Ratio of 530%
Podcasts